Clinical trials in Stockholm – page 4

252 clinical trials in Stockholm, Sweden across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SwedenKliniska-Provningar.se

Stockholm at a glance

252

clinical trials

Research sites8

Quick filters

252 trials in Stockholm

Open in trial search

Dermatitis atopic

Recruiting

Testing two moisturizing creams with urea, propylene glycol, and propylene glycol alone for preventing flare-ups in patients with atopic dermatitis

Registered drugNo placebo

Testing two moisturizing creams with urea, propylene glycol, and propylene glycol alone for preventing flare-ups in patients with atopic dermatitis

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Propylene Glycol
Sponsor:Galenica AB

Contact Research Centre

Chronic obstructive pulmonary disease

Recruiting

A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

Registered drug

A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Depemokimab
Sponsor:Glaxosmithkline Research & Development Limited

Contact Research Centre

Prostate cancer

Recruiting

A study of saruparib with radiotherapy and hormone therapy for men with high-risk prostate cancer who have a BRCA gene mutation

Registered drug

A study of saruparib with radiotherapy and hormone therapy for men with high-risk prostate cancer who have a BRCA gene mutation

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Abiraterone Acetate
Sponsor:AstraZeneca AB

Contact Research Centre

Asthma

Recruiting

Testing WIN378 Safety and Effects in Adults with Moderate or Severe Asthma

Investigational

Testing WIN378 Safety and Effects in Adults with Moderate or Severe Asthma

Investigational

Sweden

Participants:18–64 years · 65+ years
Substances:Human IgG1 monoclonal antibody against TSLP
Sponsor:Windward Bio AG

Contact Research Centre

Breast cancer+2

Recruiting

Study of PF-07248144 and fulvestrant in adults with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer who had progression after CDK4/6 inhibitor therapy

Registered drugNo placebo

Study of PF-07248144 and fulvestrant in adults with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer who had progression after CDK4/6 inhibitor therapy

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Everolimus
Sponsor:Pfizer Inc.

Contact Research Centre

Breast cancer+1

Recruiting

Study of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment

Registered drugNo placebo

Study of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Bristol-Myers Squibb Services Unlimited Company

Contact Research Centre

Major depression

Recruiting

Study of D-cycloserine with theta-burst brain stimulation for adults with major depressive disorder

Investigational

Study of D-cycloserine with theta-burst brain stimulation for adults with major depressive disorder

Investigational

Sweden

Participants:18–64 years · 65+ years
Substances:Cycloserine
Sponsor:Region Uppsala

Contact Research Centre

Colitis ulcerative

Recruiting

Study of risankizumab safety and effectiveness in children and teenagers aged 2-17 years with moderate to severe ulcerative colitis

Investigational

Study of risankizumab safety and effectiveness in children and teenagers aged 2-17 years with moderate to severe ulcerative colitis

Investigational

Sweden

Participants:0–17 years
Substances:Risankizumab
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Bipolar I disorder+1

Recruiting

Long-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) for treatment of manic episodes in adults with Bipolar I Disorder

InvestigationalNo placebo

Long-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) for treatment of manic episodes in adults with Bipolar I Disorder

InvestigationalNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Trospium Chloride
Sponsor:Bristol-Myers Squibb Services Unlimited Company

Contact Research Centre

Bipolar I disorder+1

Recruiting

Study of trospium chloride and xanomeline tartrate (KarXT) for treating manic episodes in adults with bipolar I disorder

Investigational

Study of trospium chloride and xanomeline tartrate (KarXT) for treating manic episodes in adults with bipolar I disorder

Investigational

Sweden

Participants:18–64 years
Substances:Trospium Chloride
Sponsor:Bristol-Myers Squibb Services Unlimited Company

Contact Research Centre

Respiratory syncytial virus infection

Recruiting

Study of RSVPreF3 vaccine with AS01E adjuvant in adults aged 60-65 and over 80 years to prevent respiratory syncytial virus infection

Registered drugNo placebo

Study of RSVPreF3 vaccine with AS01E adjuvant in adults aged 60-65 and over 80 years to prevent respiratory syncytial virus infection

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
Sponsor:Karolinska Institutet

Contact Research Centre

Colitis microscopic

Recruiting

Study of SAR444336 in Adults with Microscopic Colitis Who Achieved Clinical Remission with Budesonide Treatment

Investigational

Study of SAR444336 in Adults with Microscopic Colitis Who Achieved Clinical Remission with Budesonide Treatment

Investigational

Sweden

Participants:18–64 years · 65+ years
Substances:SAR444336
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Stockholm

What the registry says about research in the country

01 Oncology Research

Clinical trials focusing on metastatic prostate cancer and advanced breast cancer treatments, evaluating new therapeutic approaches and drug combinations.

Prostate Cancer Therapies
Breast Cancer Treatments
Colorectal Cancer Studies

Innovative research comparing various treatment protocols and investigating survival outcomes.

02 Infectious Diseases

Studies evaluating vaccines and treatments for respiratory syncytial virus, herpes zoster, and HPV infections.

Vaccine Development
Viral Disease Prevention
Immunization Studies

Focus on prevention and immune response in various age groups.

03 Cardiovascular Health

Research on heart failure prevention and hypertrophic cardiomyopathy, testing new therapeutic combinations.

Cardiac Arrest Management
Heart Failure Prevention
Cardiomyopathy Treatment

Emphasis on improving patient outcomes and testing novel drug combinations.

04 Neurological Disorders

Trials investigating treatments for Parkinson's disease and multiple sclerosis, focusing on disease progression and symptom management.

Disease Modification
Symptom Management
Treatment Efficacy

Studies evaluating both novel and existing therapeutic approaches.

05 Metabolic Conditions

Research on obesity and type 2 diabetes treatments, evaluating new medications for weight management.

Weight Management
Diabetes Control
Metabolic Health

Focus on lifestyle interventions combined with pharmaceutical approaches.

Back to Sweden All countries